Impact of Blood Phobia on Fainting Susceptibility
Launched by SIMON FRASER UNIVERSITY · Mar 27, 2024
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a fear of blood, injections, or injuries (known as blood-injection-injury phobia) affects people when they experience emotional stress, particularly in situations like having their blood drawn or getting an injection. Researchers want to understand how this fear influences blood pressure and can lead to fainting, which is a common reaction for those with this phobia. They are looking for both individuals who have this fear and those who do not to see how their bodies respond differently to stressful situations.
To participate in the study, you need to be between 18 and 50 years old, speak English, and can be either male or female. The study is not open to anyone with heart or nerve disorders, those who are menopausal, pregnant, or taking heart-related medications. If you join the trial, you will take part in tests that involve being in an upright position and exposed to situations that may trigger your fear, allowing researchers to observe your body's reactions. This study aims to gather important information that could help improve how we understand and treat this phobia, which can significantly impact people’s willingness to seek medical care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • male and female
- • 18 to 50 years old
- • those without a suspected BII fear and those with a suspected fear
- • english speaking
- Exclusion Criteria:
- • diagnosis of any cardiovacular or neurological disorder
- • menopausal
- • taking medication for a cardiovascular condition
- • if they are pregnant
About Simon Fraser University
Simon Fraser University (SFU) is a leading research institution based in British Columbia, Canada, renowned for its commitment to interdisciplinary studies and innovation. The university actively engages in clinical trials that advance medical knowledge and improve patient outcomes, leveraging its robust research infrastructure and collaboration with healthcare partners. SFU's dedicated team of researchers and clinicians work to address critical health challenges through rigorous scientific inquiry, ensuring adherence to ethical standards and regulatory compliance. By fostering a culture of excellence and collaboration, SFU contributes significantly to the advancement of evidence-based practices in the healthcare sector.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Burnaby, British Columbia, Canada
Patients applied
Trial Officials
Victoria E Claydon, PhD
Principal Investigator
Professor, Biomedical Physiology and Kinesiology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported